Microsomal prostaglandin E synthase is regulated by proinflammatory cytokines and glucocorticoids in primary rheumatoid synovial cells

Journal of Immunology

Volumn 167, Issue 1, 2001, Pages 469-474

  Stichtenoth, D O ^a   Thoren S ^a   Bian, H ^a   Peters Golden, M ^a   Jakobsson, P J ^a   Crofford, L J ^a  

^a UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOOXYGENASE 2; CYTOKINE; DEXAMETHASONE; GLUCOCORTICOID; INTERLEUKIN 1BETA; MESSENGER RNA; PROSTAGLANDIN E SYNTHASE; PROSTAGLANDIN E2; PROSTAGLANDIN SYNTHASE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DOSE RESPONSE; DRUG MECHANISM; ENZYME REGULATION; HUMAN; HUMAN CELL; INFLAMMATION; MICROSOME; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS; PROTEIN EXPRESSION; RHEUMATOID ARTHRITIS; SYNOVIOCYTE;

EID: 0035400078     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.167.1.469     Document Type: Article

References (37)

1. Expression and regulation of COX-2 in synovial tissues of arthritis patients
2. Basic biology and clinical application of specific COX-2 inhibitors
3. 2 at 2.2 A resolution
4. 2
5. 2
6. 2 production by the antiinflammatory cytokines interleukin-4, interleukin-10, and interleukin-13 in osteoarthritic synovial fibroblasts: Distinct targeting in the signaling pathways
7. Cyclooxygenase-1 and -2 expression in rheumatoid synovial tissues: Effects of interleukin-1β, phorbol ester, and corticosteroids
8. 2 formation
9. NF-κB in involved in the regulation of cyclooxygenase-2 expression by interleukin-1β in rheumatoid synoviocytes
10. Anti-inflammatory drugs and their mechanism of action
11. 2
12. Induction of vascular endothelial growth factor expression in synovial fibroblasts by prostaglandin E and interleukin-1: A potential mechanism for inflammatory angiogenesis
13. + T lymphocytes
14. 2 blocks inflammation, hyperalgesia, and interleukin 6 production in vivo
15. 2 in mouse bone marrow-derived mast cells
16. Increased total body synthesis of prostacyclin in rats with adjuvant arthritis
17. 2 in lipopolysaccharide-stimulated rat peritoneal macrophages
18. 2 synthesis
19. Identification of human prostaglandin E synthase: A microsomal, glutathione-dependent, inducible enzyme, constituting a potential novel drug target
20. Human glutathione dependent prostaglandin E synthase: Gene structure and regulation
21. 2 biosynthesis
22. 2 synthase that acts in concert with cyclooxygenase-2
23. Common structural features of MAPEG-a widespread superfamily of membrane associated proteins with highly divergent functions in eicosanoid and glutathione metabolism
24. A model for p53-induced apoptosis
25. Coordinate up- and down-regulation of glutathione-dependent prostaglandin E synthase and cyclooxygenase-2 in A549 cells. Inhibition by NS-398 and leukotriene C4
26. 2 and to express cyclooxygenase-2
27. 2 formation in rat carrageenin-induced pleurisy
28. Induction of cyclooxygenase-2 by interleukin-1α: Evidence for post-transcriptional regulation
29. Down-regulation of cytokine-induced cyclo-oxygenase-2 transcript isoforms by dexamethasone: Evidence for post-transcriptional regulation
30. 5-Lipoxygenase-activating protein is an arachidonate binding protein
31. Cyclooxygenase-2 up-regulation after FLAP transfection in human adenocarcinoma cell line HT29 cl.19A
32. Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: The human pharmacology of a selective inhibitor of COX-2
33. Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics and vasoactive eicosanoids
34. COX-2 and the kidneys
35. Thrombosis in patients with connective tissue diseases treated with specific COX-2 inhibitors: A report of four cases
36. Comparison of upper gastrointestinal toxicity of rofecoxib and naproxen in patients with rheumatoid arthritis: VIGOR study group
37. Altered pain perception and inflammatory response in mice tacking prostacyclin receptor